Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy
出版年份 2023 全文链接
标题
Case report: JAK1/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy
作者
关键词
-
出版物
Pediatric Rheumatology
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-26
DOI
10.1186/s12969-023-00916-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- STING-Associated Vasculopathy with Onset in infancy (SAVI) Presenting as Massive Intra Alveolar Hemorrhage
- (2023) Clara Ladoux et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
- (2022) Clémence David et al. Cells
- The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE / PRAAS , SAVI , and AGS
- (2022) Kader Cetin Gedik et al. Arthritis & Rheumatology
- Janus Kinase Inhibitors in the Treatment of Type I Interferonopathies: A Case Series From a Single Center in China
- (2022) Wendao Li et al. Frontiers in Immunology
- Role of the cGAS–STING pathway in systemic and organ-specific diseases
- (2022) Sladjana Skopelja-Gardner et al. Nature Reviews Nephrology
- Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases
- (2022) Rensheng Wan et al. Frontiers in Immunology
- STING-Mediated Lung Inflammation and Beyond
- (2021) Marie-Louise Frémond et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI)
- (2020) Bin Lin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature
- (2020) Frederik Staels et al. Frontiers in Immunology
- Familial Interstitial Lung Disease Caused by Mutation of the STING1 Gene
- (2020) Jinying Li et al. Frontiers in Pediatrics
- Stimulator of Interferon Genes-Associated Vasculopathy With Onset in Infancy: A Systematic Review of Case Reports
- (2020) YunFan Dai et al. Frontiers in Pediatrics
- Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients
- (2020) Marie-Louise Frémond et al. Journal of Allergy and Clinical Immunology-In Practice
- Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis
- (2020) Tomoya Nishida et al. INTERNAL MEDICINE
- Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome
- (2019) Stefano Volpi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models
- (2019) Mona Motwani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib
- (2019) Xiaolei Tang et al. JOURNAL OF CLINICAL IMMUNOLOGY
- JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
- (2018) Gina A. Montealegre Sanchez et al. JOURNAL OF CLINICAL INVESTIGATION
- Pro-inflammation Associated with a Gain-of-Function Mutation (R284S) in the Innate Immune Sensor STING
- (2018) Hiroyasu Konno et al. Cell Reports
- A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy
- (2018) Rohit G. Saldanha et al. Frontiers in Immunology
- Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173
- (2017) Jieun Seo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Familial chilblain lupus due to a gain-of-function mutation in STING
- (2016) Nadja König et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children
- (2016) Marie-Louise Frémond et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Failure to thrive, interstitial lung disease, and progressive digital necrosis with onset in infancy
- (2016) Justin Chia et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The infevers autoinflammatory mutation online registry: update with new genes and functions
- (2008) Florian Milhavet et al. HUMAN MUTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation